Bayer's Near-Term Outlook Dominated by Generic Pressures and Crop Science Uncertainty
Bayer’s consumer health business benefits from a narrow economic moat, largely because of its strong brand power. Consumers continue to pay a premium for Aspirin, Aleve, and other over-the-counter ...
IPWatchdog11h
Five Tactics to Improve PTAB Appeal Results for Your Clients
Over the course of my career, I have filed around 160 appeals and have guidelines that I follow to optimize my chances of ...
Cryptopolitan on MSN11h
Proposal on SEC website suggests XRP as a strategic asset for US financial system
A proposal for XRP as a strategic financial asset for the US has been published on the US Securities and Exchange Commission ...